20
Participants
Start Date
October 2, 2020
Primary Completion Date
March 1, 2026
Study Completion Date
March 1, 2029
Nivolumab
Given IV
Quality-of-Life Assessment
Ancillary studies, given in person or online
Questionnaire Administration
Ancillary studies, given in person or online
RECRUITING
Sydney Children's Hospital, Sydney
RECRUITING
The Children's Hospital at Westmead, Westmead
RECRUITING
Royal Children's Hospital, Parkville
RECRUITING
Queensland Children's Hospital, South Brisbane
RECRUITING
Women's and Children's Hospital, North Adelaide
RECRUITING
Perth Children's' Hospital, Perth
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
RECRUITING
Children's National Hospital, Washington D.C.
RECRUITING
Johns Hopkins University, Baltimore
RECRUITING
Duke Children's Hospital & Health Center, Durham
RECRUITING
University of Florida, Gainesville
RECRUITING
University of Alabama at Birmingham, Children's of Alabama, Birmingham
RECRUITING
Riley Children's Hospital, Indianapolis
RECRUITING
Washington University St. Louis, St Louis
RECRUITING
University of Utah, Salt Lake City
RECRUITING
Children's Hospital of Los Angeles, Los Angeles
RECRUITING
Rady Children's Hospital, San Diego
RECRUITING
University of California, San Francisco, San Francisco
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
Hackensack Meridian Children's Health at Joseph M. Sanzari Children's Hospital, Hackensack
Pediatric Neuro-Oncology Consortium
OTHER
Sabine Mueller, MD, PhD
OTHER